Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Daiichi Sankyo
Dow
Chubb
Moodys
Fuji
Boehringer Ingelheim
Chinese Patent Office
Citi

Generated: January 22, 2018

DrugPatentWatch Database Preview

ELIMITE Drug Profile

« Back to Dashboard

Which patents cover Elimite, and when can generic versions of Elimite launch?

Elimite is a drug marketed by Mylan Pharms Inc and is included in one NDA.

The generic ingredient in ELIMITE is permethrin. There are five drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the permethrin profile page.
Drug patent expirations by year for ELIMITE
Pharmacology for ELIMITE
Ingredient-typePyrethrins
Drug ClassPyrethroid
Medical Subject Heading (MeSH) Categories for ELIMITE

US Patents and Regulatory Information for ELIMITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc ELIMITE permethrin CREAM;TOPICAL 019855-001 Aug 25, 1989 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Moodys
Express Scripts
Harvard Business School
Citi
Argus Health
Colorcon
US Army
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot